LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Bank of America Merrill Lynch (BAML) 2017 Health Care Conference in Las Vegas and at the Jefferies (Jefferies) 2017 Global Healthcare Conference in New York City.
The discussion at the BAML conference is scheduled to begin at 9:20 a.m. Pacific Time on Tuesday, May 16, and the discussion at the Jefferies conference is scheduled to begin at 3:00 p.m. Eastern Daylight Time on Thursday, June 8. Both discussions will be available to all interested parties through a live audiocast accessible via the investor relations section of LivaNova’s website at http://investor.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the LivaNova website approximately 24 hours after the live presentation for 90 days after the event.
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London and with a presence in more than 100 countries worldwide, the company employs more than 4,500 employees. LivaNova operates as three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management, with operating headquarters in Mirandola (Italy), Houston (U.S.A.) and Clamart (France), respectively.
For more information, please visit www.livanova.com.